Study of the function and target genes of BACH transcripton factors.
BACH转录因子的功能及靶基因研究。
基本信息
- 批准号:13670778
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transcription factor BACH1 and BACH2 bind to Maf recongnition elements by dimerizing with the small Maf transcription factors. The BACH1 mRNA was abundantly expressed in erythroid-megakaryocytic lineage cells. The MARE is known to act as a critical cis element of erythroid and megakaryocytic specific genes. The BACH1 gene is localized to chromosome 21q22.1, within the potential Down's syndrome-associated gene region. Actually, BACH1 was abundantly transcribed in cel lines derived from Down's syndrome-related megakaryocytic leukemia. To investigate the in vivo role of BACH1 overexpression in hematopoiesis, we generated BACH1 transgenic mice bearing the human BACH1 gene under the control of the regulatory element of the GATA-1 gene. Peripheral blood analysis in the transgenic mice revealed a significant reduced number of platelets without anemia. Histological analysis of bone marrow disclosed that the reticulin fibers were markedly increased. Megakaryocytes from the BACH1 transgenic mice … More exhibited significantly reduced proplatelet formation and maturation arrest. These results suggest that BACH1 plays important roles in transcriptional regulation of megakaryocyte-specific genes. Next, we also show here that BACH2 modifies the in vitro cytotoxicity of anticancer drugs in lymphoid leulemic cells. The inhibition of BCR/ABL tyrosine kinase activity by STI571 in Ph1 positive lymphoid leukemic cells results in induction of BACH2 expression. The cytotoxic effects of anticancer agents were studied by overexpression of BACH2 in Raji lymphoid cells. Clones overexpressing BACH2 were more sensitive to anticancer agents producing oxidative stress than control Raji cells. Interestingly, we found that these oxidative stressors induced the nuclear accumulation of BACH2. These results show that BACH2 promotes oxidative stress-induced cell death, suggest that combination chemotherapy involving STI571 and anticancer drugs that produce ROS may be of benefit in the treatment of Ph1-positive leukemia. Less
转录因子BACH 1和BACH 2通过与小Maf转录因子二聚化而与Maf转录元件结合。BACH 1 mRNA在红系-巨核系细胞中大量表达。已知MARE作为红细胞和巨核细胞特异性基因的关键顺式元件。BACH 1基因定位于染色体21q22.1,在潜在的唐氏综合征相关基因区域内。事实上,BACH 1在唐氏综合征相关的巨核细胞白血病细胞系中大量转录。为了研究BACH 1过表达在造血中的体内作用,我们产生了携带人BACH 1基因的BACH 1转基因小鼠,该转基因小鼠在加塔-1基因的调节元件的控制下。转基因小鼠的外周血分析显示血小板数量显著减少,但没有贫血。骨髓组织学分析显示,网状硬蛋白纤维明显增加。BACH 1转基因小鼠的巨核细胞 ...更多信息 表现出显著减少的前血小板形成和成熟停滞。这些结果表明BACH 1在巨核细胞特异性基因的转录调控中起重要作用。接下来,我们还显示BACH 2在淋巴白血病细胞中改变抗癌药物的体外细胞毒性。STI 571抑制Ph 1阳性淋巴白血病细胞BCR/ABL酪氨酸激酶活性,诱导BACH 2表达。通过在Raji淋巴细胞中过表达BACH 2来研究抗癌剂的细胞毒性作用。过表达BACH 2的克隆比对照Raji细胞对产生氧化应激的抗癌剂更敏感。有趣的是,我们发现这些氧化应激诱导BACH 2的核积累。这些结果表明BACH 2促进氧化应激诱导的细胞死亡,表明涉及STI 571和产生ROS的抗癌药物的联合化疗可能有益于治疗Ph 1阳性白血病。少
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kanazaki R, Toki T, Yokoyama M, Yomogida K, Sugiyama K, Yamamoto M, Igarashi K, Ito E: "Transcription factor BACH1 is recruited to the nucleus by its novel alternative spliced isoform"Journal of Biological Chemistry. 276-9. 7276-7284 (2001)
Kanazaki R、Toki T、Yokoyama M、Yomogida K、Sugiyama K、Yamamoto M、Igarashi K、Ito E:“转录因子 BACH1 通过其新颖的选择性剪接亚型被招募到细胞核”《生物化学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
丹代 諭, 佐藤秀子, 金崎里香, 土岐 力, 伊藤悦朗, 五十嵐和彦: "B細胞特異的転写因子BACH2によるBCL-2関連遺伝子Alの発現抑制機構"弘前医学. 54. 8-20 (2002)
Satoshi Tanyo、Hideko Sato、Rika Kanazaki、Chikara Toki、Etsuro Ito、Kazuhiko Igarashi:“B 细胞特异性转录因子 BACH2 抑制 BCL-2 相关基因 A1 表达的机制”弘前医学科学 54. 8-20。 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kanazaki R, Toki T, Yokoyama M, Yomogida K, Sugiyama K, Yamamoto M, Igarashi K, Ito E: "Transcription factor BACH1 is recruited to the nucleus by its novel alternative spliced isoform"Journal of Biological Chemistry. 276. 7278-7284 (2001)
Kanazaki R、Toki T、Yokoyama M、Yomogida K、Sugiyama K、Yamamoto M、Igarashi K、Ito E:“转录因子 BACH1 通过其新颖的选择性剪接亚型被招募到细胞核”《生物化学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tandai S, Sato H, Kanezaki R, Toki T, Ito E, Igarashi K: "B cell specific transcription factor BACH2 negatively reglates expression of BCL-2 rekated A1 gene."Hirosaki Medical Journal. 54-1. 8-20 (2002)
Tandai S、Sato H、Kanezaki R、Toki T、Ito E、Igarashi K:“B 细胞特异性转录因子 BACH2 负向调节 BCL-2 相关 A1 基因的表达。”弘前医学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOKI Tsutomu其他文献
TOKI Tsutomu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOKI Tsutomu', 18)}}的其他基金
Investigation of cis-elements recognized by mutatnt GATA1 by chromation immunoprecipitation sequencing analysis
通过染色免疫沉淀测序分析研究突变体 GATA1 识别的顺式元件
- 批准号:
25461579 - 财政年份:2013
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Isolation of novel class I mutation in infantile acute myeloid
婴儿急性髓细胞新型 I 类突变的分离
- 批准号:
21591344 - 财政年份:2009
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional characterization of transcription factor BACH-1 and GATA-1 in phenotype of acute megakaryocytic leukemia
转录因子BACH-1和GATA-1在急性巨核细胞白血病表型中的功能特征
- 批准号:
19591236 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The differential regulation of target genes by transcription factor BACH 1 in erythroid and megakaryocytic cells.
红细胞和巨核细胞中转录因子 BACH 1 对靶基因的差异调节。
- 批准号:
17591066 - 财政年份:2005
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of transcription factor BACH1 on thrombopiesis and megakaryocyte diffrentiation
转录因子BACH1对血栓形成和巨核细胞分化的功能分析
- 批准号:
15591079 - 财政年份:2003
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The role of protein glycosylation in erythropoiesis
蛋白质糖基化在红细胞生成中的作用
- 批准号:
DP240100832 - 财政年份:2024
- 资助金额:
$ 2.18万 - 项目类别:
Discovery Projects
Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q
破译MDS-5q无效红细胞生成的分子机制
- 批准号:
10773217 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Elucidating the mechanism of erythropoiesis through the search for transcription factors targeted by deubiquitinating enzyme X.
通过寻找去泛素化酶 X 靶向的转录因子来阐明红细胞生成机制。
- 批准号:
23K15310 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigating PUM1 mediated post-transcriptional regulation of human hemoglobin switching and erythropoiesis
研究 PUM1 介导的人血红蛋白转换和红细胞生成的转录后调节
- 批准号:
10568059 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Deciphering a Novel Mechanism for Iron-sensing at Mitochondria and Its Role in Erythropoiesis
破译线粒体铁感应的新机制及其在红细胞生成中的作用
- 批准号:
10560352 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
EpoR & Stat5 regulation of ribosome biogenesis and protein synthesis in erythropoiesis
EPR
- 批准号:
10682214 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Developing an inhibitor of EIF2AK1 to overcome ineffective erythropoiesis in myelodysplastic syndromes with ringed sideroblasts
开发 EIF2AK1 抑制剂以克服环状铁粒幼细胞骨髓增生异常综合征中无效的红细胞生成
- 批准号:
10726479 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Mechanisms and consequences of 3'UTR isoform diversity in erythropoiesis
红细胞生成中 3UTR 亚型多样性的机制和后果
- 批准号:
10387610 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别: